TLDR PCOS increases the risk of heart disease and type 2 diabetes in women.
Polycystic ovary syndrome (PCOS) was identified as the most common female endocrinopathy, affecting up to 10% of women of reproductive age, and was associated with increased cardiovascular risk. The syndrome, characterized by chronic anovulation and hyperandrogenism, was linked to potential long-term consequences, including cardiovascular disease and type 2 diabetes. This connection highlighted the importance of examining PCOS beyond its gynecological implications to understand its broader impact on women's health, particularly in relation to cardiovascular disease risk post-menopause.
1744 citations,
November 2006 in “The Journal of Clinical Endocrinology and Metabolism” Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.
430 citations,
July 2002 in “Journal of Endocrinology” The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.
61 citations,
February 2001 in “American Journal of Obstetrics and Gynecology” Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.
491 citations,
July 2000 in “The Journal of Clinical Endocrinology and Metabolism” Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.
633 citations,
September 1998 in “The Journal of Clinical Endocrinology and Metabolism” PCOS affects a similar percentage of Black and White women in the Southeastern United States.
1947 citations,
September 1995 in “New England journal of medicine/The New England journal of medicine” PCOS is a common hormonal disorder causing irregular periods and increased hair growth, linked to insulin resistance and long-term health issues.
